Antiviral Effect of Budesonide against SARS-CoV-2
Treatment options for COVID-19, a disease caused by <i>Severe</i> <i>Acute</i> <i>Respiratory</i> <i>Syndrome</i> Coronavirus 2 (SARS-CoV-2) infection, are currently severely limited. Therefore, antiviral drugs that efficiently reduce SARS-CoV-2 replication or alleviate COVID-19 symptoms are urgentl...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI AG
2021-07-01
|
| Cyfres: | Viruses |
| Pynciau: | |
| Mynediad Ar-lein: | https://www.mdpi.com/1999-4915/13/7/1411 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|